About:
Posts by :
-
June 2, 2013 Akt inhibition for cancer treatment, where do we stand today?
-
June 1, 2013 FDA approved two drugs and a companion diagnostic test for the treatment of advanced or unresectable cutaneous melanoma patients
-
May 22, 2013 Soft Tissue Sarcoma: an Overview
-
May 9, 2013 The Development of siRNA-Based Therapies for Cancer
-
April 23, 2013 Whole exome somatic mutations analysis of malignant melanoma contributes to the development of personalized cancer therapy for this disease
-
April 6, 2013 Targeting Mitochondrial-bound Hexokinase for Cancer Therapy
-
March 25, 2013 Cancer Screening at Sourasky Medical Center Cancer Prevention Center in Tel-Aviv
-
March 16, 2013 A P(hD)aradox
-
March 7, 2013 The Importance of Cancer Prevention Programs: New Percpectives for Fighting Cancer
Follow Blog via Email
Join 2,038 other subscribers-
Recent Posts
- Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
- FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
Archives
Categories
Meta